Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00818077 · ClinicalTrials.gov registry record
Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food
A clinical trial of Type 2 Diabetes and Currently Taking Metformin, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT00818077: Completed study of Type 2 Diabetes and Currently Taking Metformin, sponsored by HealthPartners Institute.
NCT00818077 is a study of Type 2 Diabetes and Currently Taking Metformin that has completed, run by HealthPartners Institute. The registered enrollment target is 15 participants, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00818077, a study of Type 2 Diabetes and Currently Taking Metformin, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will look at the impact that meals have on blood glucose (sugar) levels. Subjects will be asked to use a Continuous Glucose Monitoring System (CGM), which monitors glucose levels continuously. Breakfast and lunch meals will be provided and must be consumed at the International Diabetes Center.
Conditions Studied
Interventions
- OTHER Continuous Glucose Monitoring of Carbohydrate Intake
Study Locations (1)
Minnesota
- International Diabetes Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-09 |
What the finished NCT00818077 record still lists
NCT00818077 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitoring of Carbohydrate Intake is the first listed.
NCT00818077 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00818077 about?
NCT00818077 is a clinical study titled "Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food". This study will look at the impact that meals have on blood glucose (sugar) levels. Subjects will be asked to use a Continuous Glucose Monitoring System (CGM), which monitors glucose levels continuously. Breakfast and lunch meals will be provided and must be consumed at the International Diabetes Ce...
What is the current status of trial NCT00818077?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2008-01. Estimated completion is 2010-09.
What conditions does trial NCT00818077 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Currently Taking Metformin.
What interventions are being tested in trial NCT00818077?
The interventions under investigation include: Continuous Glucose Monitoring of Carbohydrate Intake (OTHER).
Who is sponsoring clinical trial NCT00818077?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00818077 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00818077's enrollment target sits among peer trials
15 308th of 327 higher than 17 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
Mechanism of SGLT2 Inhibition in the Kidney
RECRUITING · Phase 4
-
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia